Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.70 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.67 |
| ▸ | ACR | P10323 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30373246 | 1.00 | SLC6A3 (1.00) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL6813193 | 0.95 | SLC6A3 (0.90) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL5706076 | 0.93 | SLC6A3 (0.87) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL7871178 | 0.92 | SLC6A3 (0.84) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL5706114 | 0.90 | SLC6A3 (0.81) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL7615922 | 0.88 | SLC6A3 (0.79) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL6812283 | 0.88 | SLC6A3 (0.79) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL5706028 | 0.87 | SLC6A3 (0.77) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL5706030 | 0.87 | SLC6A3 (0.77) | SLC6A3MAPTKMT2APRSS1ACR | |
| SCHEMBL1058373 | 0.87 | SLC6A3 (0.77) | SLC6A3MAPTKMT2APRSS1ACR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1257920-C | Catalyst component for olefinic polymerization and its catalyst | CHINA PETROLEUM & CHEMICAL (CN) | 2006-05-31 | — | — | CN | claimed |
| CN-1611515-A | Catalyst component for olefinic polymerization and its catalyst | CHINA PETROCHEMICAL CO LTD (CN) | 2005-05-04 | — | — | CN | claimed |
| EP-0250210-B1 | METHOD OF FABRICATING METAL-CERAMIC COMPOSITES, AND METAL-CERAMIC COMPOSITES MADE THEREBY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-04-22 | — | — | EP | claimed |
| EP-2365957-B1 | METHOD FOR MAKING CARBONATES AND ESTERS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2020-04-22 | — | — | EP | disclosed |
| US-9351980-B2 | Di-aspirin derivatives | THE UNIVERSITY OF WOLVERHAMPTON (GB) | 2016-05-31 | — | — | US | disclosed |
| US-9351980-B2 | Di-aspirin derivatives | THE UNIVERSITY OF WOLVERHAMPTON (GB) | 2016-05-31 | — | — | US | disclosed |
| WO-2014122664-A1 | LANTHANIDE CLUSTERS AND METHODS OF USE THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2014-08-14 | — | — | WO | disclosed |
| US-20130035317-A1 | Di-Aspirin Derivatives | THE UNIVERISTY OF WOLVERHAMPTON (GB) | 2013-02-07 | — | — | US | disclosed |
| US-20130035317-A1 | Di-Aspirin Derivatives | THE UNIVERISTY OF WOLVERHAMPTON (GB) | 2013-02-07 | — | — | US | disclosed |
| EP-2365957-A2 | METHOD FOR MAKING CARBONATES AND ESTERS | SABIC Innovative Plastics IP B.V. (NL) | 2011-09-21 | — | — | EP | disclosed |
| WO-2011098839-A2 | DI-ASPIRIN DERIVATIVES | THE UNIVERSITY OF WOLVERHAMPTON (GB) | 2011-08-18 | — | — | WO | disclosed |
| US-20030088051-A1 | Process for preparing polycarbonate and apparatus for preparing polycarbonate | GENERAL ELECTRIC COMPANY | 2003-05-08 | — | — | US | disclosed |
| CN-1380896-A | Aromatic polycarbonate composition, process for producing the same, and molded article thereof | TEIJIN LTD (JP) | 2002-11-20 | — | — | CN | disclosed |
| CN-1351632-A | Aromatic polycarbonate composition | TEIJIN LTD (JP) | 2002-05-29 | — | — | CN | disclosed |
| US-6323302-B1 | SUPPLYING AROMATIC DIHYDROXY COMPOUND POWDER AND A CARBONIC ACID DIESTER INTO MELTING VESSEL THROUGH A TRANSPORTATION PIPING; MIXING MELTING; INITIATING MELT POLYMERIZATION IN PRESENCE OR ABSENCE OF CATALYST | TEIJIN LIMITED (JP) | 2001-11-27 | — | — | US | disclosed |
| US-6303734-B1 | HIGH STABILITY TO THE DETERIORATION OF THE COLOR OF CHIPS STORED IN AIR AT ROOM TEMPERATURE BY SUPPRESSING THE RELATIVE INTENSITY OF FLUORESCENT LIGHT TO 4.0 X.10(TO-3) OR BELOW | TEIJIN LIMITED (JP) | 2001-10-16 | — | — | US | disclosed |
| CN-1252817-A | Process for producing polycarbonate resin | TEIJIN LTD (JP) | 2000-05-10 | — | — | CN | disclosed |
| EP-0992522-A1 | CARBONIC DIESTER, AROMATIC POLYCARBONATE, PRODUCTION APPARATUS, AND PROCESS FOR PRODUCTION | TEIJIN LIMITED (JP) | 2000-04-12 | — | — | EP | disclosed |
| EP-0985696-A1 | STABILIZED AROMATIC POLYCARBONATE | TEIJIN LIMITED (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0976772-A1 | PROCESS FOR PRODUCING POLYCARBONATE RESIN | TEIJIN LIMITED (JP) | 2000-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035317-A1 | Di-Aspirin Derivatives | SDHA, DLD, DPYD | SLC6A3 2921/4885MAPT 4504/4885KMT2A 2755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.